Sunmark Loratadine ODT

Manufacturer: Sunmark | Ranbaxy Pharmaceuticals Inc. | Ohm Laboratories Inc.
Effective date: 2012-08-14
Label type: HUMAN OTC DRUG LABEL
Version: 2
Source: full-release
Hydrated at: 2026-05-31 22:32:50

Label at a glance#

ProductSunmark Loratadine ODT

Active ingredientLORATADINE

Label structure9 sections

Indications and uses

temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nose itchy, watery eyes sneezing itching of the nose or throat

Dosage and administration

place 1 tablet on tongue; tablet disintegrates, with or without water adults and children 6 years and over 1 tablet daily; not more than 1 tablet in 24 hours children under 6 years of age ask a doctor consumers with liver or kidney disease ask a doctor

Contacts and useful links#

PhonePoison Help1-800-222-1222

PhoneLabel contact1-800-406-7984

Websitewww.sunmarkbrand.com

www.sunmarkbrand.com

Label contents#

Full prescribing information#

ACTIVE INGREDIENT (IN EACH TABLET)

OTC - ACTIVE INGREDIENT SECTION

Loratadine, USP 10 mg

PURPOSE

OTC - PURPOSE SECTION

Antihistamine

USES

INDICATIONS & USAGE SECTION

temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:

runny nose
itchy, watery eyes
sneezing
itching of the nose or throat

WARNINGS

WARNINGS SECTION

Do not use

OTC - DO NOT USE SECTION

if you have ever had an allergic reaction to this product or any of its ingredients.

Ask a doctor before use if you have

OTC - ASK DOCTOR SECTION

liver or kidney disease. Your doctor should determine if you need a different dose.

When using this product

OTC - WHEN USING SECTION

do not take more than directed. Taking more than directed may cause drowsiness.

Stop use and ask a doctor if

OTC - STOP USE SECTION

an allergic reaction to this product occurs. Seek medical help right away.

If pregnant or breast-feeding,

OTC - PREGNANCY OR BREAST FEEDING SECTION

ask a health professional before use.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

DIRECTIONS

DOSAGE & ADMINISTRATION SECTION

place 1 tablet on tongue; tablet disintegrates, with or without water
adults and children 6 years and over 1 tablet daily; not more than 1 tablet in 24 hours
children under 6 years of age ask a doctor
consumers with liver or kidney disease ask a doctor

OTHER INFORMATION

SPL UNCLASSIFIED SECTION

Phenylketonurics: Contains Phenylalanine 0.6 mg Per Tablet.
TAMPER EVIDENT: DO NOT USE IF BLISTER UNITS ARE TORN, BROKEN OR SHOW ANY SIGNS OF TAMPERING.
store between 20° to 25° C (68° to 77° F). Protect from excessive moisture.
keep in a dry place.
use tablet immediately after opening individual blister.

INACTIVE INGREDIENTS

INACTIVE INGREDIENT SECTION

aspartame, croscarmellose sodium, fruit flavors, magnesium stearate, mannitol, sodium stearyl fumarate

QUESTIONS?

OTC - QUESTIONS SECTION

call 1-800-406-7984

Keep the carton. It contains important information.

See end panel for expiration date.

Distributed by McKesson

One Post Street, San Francisco, CA 94104

www.sunmarkbrand.com

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

sunmark^®

NDC 49348-930-01

allergy relief

24 HOUR

loratadine Orally Disintegrating Tablets, 10 mg

Antihistamine

For adults and children six years and older

Indoor & Outdoor Allergies

Non-drowsy^*

Relief of sneezing; runny nose; itchy, watery eyes; itchy throat or nose

MELTS IN YOUR MOUTH

10 ORALLY DISINTEGRATING TABLETS

^*When taken as directed.

See Drug Facts Panel.

COMPARE TO CLARITIN^®REDITABS^®ACTIVE INGREDIENT^†

^†The product is not manufactured or distributed by Schering-Plough Healthcare Products , Inc.

CLARITIN^®and REDITABS^®are registered trademarks of Schering Corporation.

sunmark^®

NDC 49348-929-04

allergy relief

24 HOUR

Loratadine Orally Disintegrating Tablets, 10 mg

Antihistamine

For adults and children six years and older

Indoor & Outdoor Allergies

Non-drowsy^*

Relief of sneezing; runny nose; itchy, watery eyes; itching of nose & throat

MELTS IN YOUR MOUTH

24 ORALLY DISINTEGRATING TABLETS

^*When taken as directed.

See Drug Facts Panel.

COMPARE TO ALAVERT^®ACTIVE INGREDIENT^†

^†The product is not manufactured or distributed by Wyeth Consumer Healthcare, owner of the registered trademark Alavert^®.

This is the 24 count blister carton label for Sunmark Loratadine ODT (Alavert).

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	SPL version
311373	loratadine 10 MG 24HR Disintegrating Oral Tablet	PSN	2
311373	loratadine 10 MG Disintegrating Oral Tablet	SCD	2

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
a62a50ac-1535-4461-9768-8ae703e2e9fb	Product name	1	20210525
9514609b-a2a9-f8ec-6ba6-3f8e5ee89877	Product name	1	20140508
bc07ef78-e82d-0c19-31f4-31f263780582	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
49348-929-04	2020-01-31	C162847	48780-1	9d75b9d0-2e27-f424-e053-dadaa90a57ce	Drug Facts
49348-930-01	2020-01-31	C162847	48780-1	9d75b9d0-2e27-f424-e053-dadaa90a57ce	Drug Facts
49348-930-44	2020-01-31	C162847	48780-1	9d75b9d0-2e27-f424-e053-dadaa90a57ce	Drug Facts

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
49348-929-04	Sunmark Loratadine ODT	24 in 1 BLISTER PACK	TABLET, ORALLY DISINTEGRATING	24	2
49348-930-01	Sunmark Loratadine ODT	10 in 1 BLISTER PACK	TABLET, ORALLY DISINTEGRATING	10	2
49348-930-44	Sunmark Loratadine ODT	30 in 1 BLISTER PACK	TABLET, ORALLY DISINTEGRATING	30	2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
49348-929	SUNMARK LORATADINE ODT (LORATADINE) TABLET, ORALLY DISINTEGRATING [SUNMARK]	2	Legacy NDC, 1 package rows	20120822_2aa10bc8-4d85-49c8-ad9b-7a555b26fe0d.zip
49348-930	SUNMARK LORATADINE ODT (LORATADINE) TABLET, ORALLY DISINTEGRATING [SUNMARK]	2	Legacy NDC, 2 package rows	20120822_2aa10bc8-4d85-49c8-ad9b-7a555b26fe0d.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
49348-930-01	EA - Each	49348-930	737252da-9d20-4e22-9913-bfa002f45e84	1	2013-02-13
49348-930-44	EA - Each	49348-930	2e892c48-66bd-4f93-a763-e2834271bb4e	1	2013-02-13
49348-929-04	EA - Each	49348-929	7e79d2cb-30d4-4b76-9b88-279abacb563b	1	2013-02-13

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
LORATADINE	ACTIVE INGREDIENT	7AJO3BO7QN	2
LORATADINE	ACTIVE MOIETY	7AJO3BO7QN	2
ASPARTAME	INACTIVE INGREDIENT	Z0H242BBR1	2
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	2
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	2
MANNITOL	INACTIVE INGREDIENT	3OWL53L36A	2
SODIUM STEARYL FUMARATE	INACTIVE INGREDIENT	7CV7WJK4UI	2

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 7 matching rows.

Sunmark Loratadine ODT
Loratadine
ASPARTAME
CROSCARMELLOSE SODIUM
MAGNESIUM STEARATE
MANNITOL
SODIUM STEARYL FUMARATE

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
49348-930	49348-930-01, 49348-930-44
49348-929	49348-929-04

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 12 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
LORATADINE	7AJO3BO7QN	ACTIB
ASPARTAME	Z0H242BBR1	IACT
CROSCARMELLOSE SODIUM	M28OL1HH48	IACT
MAGNESIUM STEARATE	70097M6I30	IACT
MANNITOL	3OWL53L36A	IACT
SODIUM STEARYL FUMARATE	7CV7WJK4UI	IACT
LORATADINE	7AJO3BO7QN	ACTIB
ASPARTAME	Z0H242BBR1	IACT
CROSCARMELLOSE SODIUM	M28OL1HH48	IACT
MAGNESIUM STEARATE	70097M6I30	IACT
MANNITOL	3OWL53L36A	IACT
SODIUM STEARYL FUMARATE	7CV7WJK4UI	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 3 · 162 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
MANNITOL	MANNITOL	3OWL53L36A	POWDER, FOR SUSPENSION / INTRAMUSCULAR	6.75 %w/v		Exact identifier — unii candidate 65 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	SUSPENSION, EXTENDED RELEASE / ORAL	2464.6 mg		Exact identifier — unii candidate 65 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	POWDER, FOR SOLUTION / ORAL		3767 mg	Exact identifier — unii candidate 65 equally ranked IID candidates
SODIUM STEARYL FUMARATE	SODIUM STEARYL FUMARATE	7CV7WJK4UI	GRANULE, FOR SOLUTION / ORAL	18.2 mg/120ml		Exact identifier — unii candidate 17 equally ranked IID candidates
ASPARTAME	ASPARTAME	Z0H242BBR1	POWDER, FOR SOLUTION / ORAL	233 mg		Exact identifier — unii candidate 19 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	INHALANT / ORAL	0.08 mg		Exact identifier — unii candidate 39 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	SOLUTION / ORAL		869 mg	Exact identifier — unii candidate 65 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET, FILM COATED / ORAL		96 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	SOLUTION, GEL FORMING, EXTENDED RELEASE / OPHTHALMIC	4.35 %w/w		Exact identifier — unii candidate 65 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	GRANULE, FOR SUSPENSION / ORAL		14 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
CROSCARMELLOSE SODIUM	CROSCARMELLOSE SODIUM	M28OL1HH48	TABLET, DELAYED RELEASE / ORAL		280 mg	Exact identifier — unii candidate 22 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS		15400 mg	Exact identifier — unii candidate 65 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	LOZENGE / TRANSMUCOSAL		100 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
CROSCARMELLOSE SODIUM	CROSCARMELLOSE SODIUM	M28OL1HH48	CAPSULE, DELAYED RELEASE PELLETS / ORAL		127 mg	Exact identifier — unii candidate 22 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	INJECTION / INTRAMUSCULAR	106.6 mg		Exact identifier — unii candidate 65 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	GUM, CHEWING / BUCCAL		891 mg	Exact identifier — unii candidate 65 equally ranked IID candidates
CROSCARMELLOSE SODIUM	CROSCARMELLOSE SODIUM	M28OL1HH48	CAPSULE, EXTENDED RELEASE / ORAL		53 mg	Exact identifier — unii candidate 22 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	SUSPENSION / OPHTHALMIC		9 mg	Exact identifier — unii candidate 65 equally ranked IID candidates
ASPARTAME	ASPARTAME	Z0H242BBR1	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL		78 mg	Exact identifier — unii candidate 19 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	SOLUTION, CONCENTRATE / INTRAVENOUS		220 mg	Exact identifier — unii candidate 65 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	INJECTION, POWDER, FOR SOLUTION / PARENTERAL	200 mg		Exact identifier — unii candidate 65 equally ranked IID candidates
CROSCARMELLOSE SODIUM	CROSCARMELLOSE SODIUM	M28OL1HH48	INJECTION / INTRAMUSCULAR	1 %w/v		Exact identifier — unii candidate 22 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET / ORAL		980 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
ASPARTAME	ASPARTAME	Z0H242BBR1	SUSPENSION / ORAL		23 mg	Exact identifier — unii candidate 19 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	LOZENGE / ORAL		420 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	POWDER, FOR SUSPENSION / ORAL		120 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL		47 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
ASPARTAME	ASPARTAME	Z0H242BBR1	TABLET, ORALLY DISINTEGRATING / ORAL		180 mg	Exact identifier — unii candidate 19 equally ranked IID candidates
SODIUM STEARYL FUMARATE	SODIUM STEARYL FUMARATE	7CV7WJK4UI	LOZENGE / ORAL		125 mg	Exact identifier — unii candidate 17 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET / SUBLINGUAL	17.5 mg		Exact identifier — unii candidate 39 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL		1568 mg	Exact identifier — unii candidate 65 equally ranked IID candidates
CROSCARMELLOSE SODIUM	CROSCARMELLOSE SODIUM	M28OL1HH48	TABLET / ORAL		736 mg	Exact identifier — unii candidate 22 equally ranked IID candidates
ASPARTAME	ASPARTAME	Z0H242BBR1	GRANULE, FOR SUSPENSION / ORAL		420 mg	Exact identifier — unii candidate 19 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET, FOR SUSPENSION / ORAL		131 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	INJECTION / SUBCUTANEOUS		675 mg	Exact identifier — unii candidate 65 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	SPRAY / NASAL	41.5 mg		Exact identifier — unii candidate 65 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	WAFER / ORAL	66 mg		Exact identifier — unii candidate 39 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	SOLUTION / INTRAVENOUS		15400 mg	Exact identifier — unii candidate 65 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	CAPSULE, EXTENDED RELEASE / ORAL		117 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	INJECTION, POWDER, FOR SUSPENSION / SUBCUTANEOUS		180 mg	Exact identifier — unii candidate 65 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	TABLET, ORALLY DISINTEGRATING / SUBLINGUAL	10.25 mg		Exact identifier — unii candidate 65 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	POWDER / TOPICAL		104 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
ASPARTAME	ASPARTAME	Z0H242BBR1	POWDER / ORAL		63 mg	Exact identifier — unii candidate 19 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	LOZENGE / ORAL		20546 mg	Exact identifier — unii candidate 65 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS		658 mg	Exact identifier — unii candidate 65 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	PELLET / ORAL		24 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	POWDER / ORAL		4352 mg	Exact identifier — unii candidate 65 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	INJECTION, SUSPENSION / INTRAVENOUS	2.5 %w/v		Exact identifier — unii candidate 65 equally ranked IID candidates
CROSCARMELLOSE SODIUM	CROSCARMELLOSE SODIUM	M28OL1HH48	TABLET, FILM COATED / ORAL		330 mg	Exact identifier — unii candidate 22 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	TABLET, EXTENDED RELEASE / ORAL		1086 mg	Exact identifier — unii candidate 65 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	DROPS / ORAL	NA		Exact identifier — unii candidate 39 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	INSERT / VAGINAL		69 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	SOLUTION/ DROPS / OPHTHALMIC	4.6 %w/v		Exact identifier — unii candidate 65 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	TABLET, FOR SUSPENSION / ORAL		7621 mg	Exact identifier — unii candidate 65 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET, DELAYED RELEASE / ORAL		144 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	SOLUTION, GEL FORMING / DROPS / OPHTHALMIC		4 mg	Exact identifier — unii candidate 65 equally ranked IID candidates
CROSCARMELLOSE SODIUM	CROSCARMELLOSE SODIUM	M28OL1HH48	TROCHE / ORAL		50 mg	Exact identifier — unii candidate 22 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	IMPLANT / SUBCUTANEOUS	0.5 mg		Exact identifier — unii candidate 39 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	POWDER / RESPIRATORY (INHALATION)		6 mg	Exact identifier — unii candidate 65 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	SUSPENSION/ DROPS / OPHTHALMIC	3.3 %w/v		Exact identifier — unii candidate 65 equally ranked IID candidates

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A077153-001	LORATADINE REDIDOSE	LORATADINE	10MG	TABLET, ORALLY DISINTEGRATING / ORAL			2007-04-11

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	A077153-001	LORATADINE REDIDOSE	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	2007-04-11	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A077153-001	LORATADINE REDIDOSE	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	2007-04-11	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A077153-001	LORATADINE REDIDOSE	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	2007-04-11	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077153-001	LORATADINE REDIDOSE	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	2007-04-11	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A077153-001	LORATADINE REDIDOSE	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	2007-04-11	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077153-001	LORATADINE REDIDOSE	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	2007-04-11	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077153-001	LORATADINE REDIDOSE	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	2007-04-11	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077153-001	LORATADINE REDIDOSE	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	2007-04-11	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A077153-001	LORATADINE REDIDOSE	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	2007-04-11	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A077153-001	LORATADINE REDIDOSE	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	2007-04-11	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A077153-001	LORATADINE REDIDOSE	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	2007-04-11	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A077153-001	LORATADINE REDIDOSE	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	2007-04-11	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A077153-001	LORATADINE REDIDOSE	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	2007-04-11	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A077153-001	LORATADINE REDIDOSE	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	2007-04-11	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A077153-001	LORATADINE REDIDOSE	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	2007-04-11	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A077153-001	LORATADINE REDIDOSE	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	2007-04-11	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A077153-001	LORATADINE REDIDOSE	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	2007-04-11	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A077153-001	LORATADINE REDIDOSE	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	2007-04-11	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A077153-001	LORATADINE REDIDOSE	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	2007-04-11	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A077153-001	LORATADINE REDIDOSE	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	2007-04-11	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A077153-001	LORATADINE REDIDOSE	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	2007-04-11	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A077153-001	LORATADINE REDIDOSE	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	2007-04-11	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A077153-001	LORATADINE REDIDOSE	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	2007-04-11	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A077153-001	LORATADINE REDIDOSE	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	2007-04-11	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A077153-001	LORATADINE REDIDOSE	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	2007-04-11	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A077153-001	LORATADINE REDIDOSE	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	2007-04-11	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A077153-001	LORATADINE REDIDOSE	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	2007-04-11	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A077153-001	LORATADINE REDIDOSE	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	2007-04-11	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A077153-001	LORATADINE REDIDOSE	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	2007-04-11	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A077153-001	LORATADINE REDIDOSE	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	2007-04-11	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A077153-001	LORATADINE REDIDOSE	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	2007-04-11	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A077153-001	LORATADINE REDIDOSE	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	2007-04-11	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A077153-001	LORATADINE REDIDOSE	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	2007-04-11	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A077153-001	LORATADINE REDIDOSE	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	2007-04-11	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A077153-001	LORATADINE REDIDOSE	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	2007-04-11	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A077153-001	LORATADINE REDIDOSE	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	2007-04-11	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A077153-001	LORATADINE REDIDOSE	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	2007-04-11	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A077153-001	LORATADINE REDIDOSE	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	2007-04-11	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A077153-001	LORATADINE REDIDOSE	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	2007-04-11	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A077153-001	LORATADINE REDIDOSE	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	2007-04-11	`f41ea6bd6efb…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
e1e28a49-a526-42b0-8a64-c3546094962f			2aa10bc8-4d85-49c8-ad9b-7a555b26fe0d	2012-08-14	Warnings	Exact identifier spl id: e1e28a49-a526-42b0-8a64-c3546094962f spl set id: 2aa10bc8-4d85-49c8-ad9b-7a555b26fe0d

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

adults and children 6 years and over	1 tablet daily; not more than 1 tablet in 24 hours
children under 6 years of age	ask a doctor
consumers with liver or kidney disease	ask a doctor